NasdaqCM - Nasdaq Real Time Price USD

Carisma Therapeutics, Inc. (CARM)

0.6201
+0.0719
+(13.12%)
As of 9:50:24 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
19,964
19,632
14,919
9,834
0
Operating Expense
71,967
81,811
103,650
65,996
40,794
Operating Income
-52,003
-62,179
-88,731
-56,162
-40,794
Net Non Operating Interest Income Expense
1,238
1,702
1,936
-3,145
10
Other Income Expense
--
--
-84
-1,919
--
Pretax Income
-50,765
-60,477
-86,879
-61,226
-40,784
Net Income Common Stockholders
-50,765
-60,477
-86,879
-61,226
-40,784
Diluted NI Available to Com Stockholders
-50,765
-60,477
-86,879
-61,226
-40,784
Basic EPS
-1.22
-1.46
-2.59
-1.52
-1.01
Diluted EPS
-1.22
-1.46
-2.59
-1.52
-1.01
Basic Average Shares
41,664.3970
41,456.2100
33,524.1970
40,254.6660
40,254.6660
Diluted Average Shares
41,664.3970
41,456.2100
33,524.1970
40,254.6660
40,254.6660
Total Operating Income as Reported
-52,003
-62,179
-88,731
-56,162
-40,794
Total Expenses
71,967
81,811
103,650
65,996
40,794
Net Income from Continuing & Discontinued Operation
-50,765
-60,477
-86,879
-61,226
-40,784
Normalized Income
-50,765
-60,477
-86,795
-59,307
-40,784
Interest Income
--
1,702
1,936
--
10
Interest Expense
--
--
--
3,145
--
Net Interest Income
1,238
1,702
1,936
-3,145
10
EBIT
-52,003
-62,179
-88,731
-58,081
-40,794
EBITDA
-49,681
-58,825
-85,894
-56,188
-40,112
Reconciled Depreciation
2,322
3,354
2,837
1,893
682
Net Income from Continuing Operation Net Minority Interest
-50,765
-60,477
-86,879
-61,226
-40,784
Total Unusual Items Excluding Goodwill
--
--
-84
-1,919
--
Total Unusual Items
--
--
-84
-1,919
--
Normalized EBITDA
-49,681
-58,825
-85,810
-54,269
-40,112
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 2/6/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

KLTO Klotho Neurosciences, Inc.
1.9150
-4.25%
 
NCNA NuCana plc
0.1351
-11.12%
 
EVGN Evogene Ltd.
1.3605
-10.44%
 
PHAT Phathom Pharmaceuticals, Inc.
10.61
+5.79%
 
INSM Insmed Incorporated
96.86
-0.03%
 
KZIA Kazia Therapeutics Limited
9.06
-7.46%
 
EYEN Eyenovia, Inc.
3.0310
+13.52%
 
VXRT Vaxart, Inc.
0.5137
-4.34%
 
NKTR Nektar Therapeutics
8.31
-5.14%
 
RXRX Recursion Pharmaceuticals, Inc.
5.08
-1.81%